Literature DB >> 8876216

The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand.

M Orihuela1, D H Margulies, W M Yokoyama.   

Abstract

Natural killer (NK) cells are inhibited from killing cellular targets by major histocompatibility complex (MHC) class I molecules. In the mouse, this can be mediated by the Ly-49A NK cell receptor that specifically binds the H-2Dd MHC class I molecule, then inhibits NK cell activity. Previous experiments have indicated that Ly-49A recognizes the alpha 1/alpha 2 domains of MHC class I and that no specific MHC-bound peptide appeared to be involved. We demonstrate here that alanine-substituted peptides, having only the minimal anchor motifs, stabilized H-2Dd expression and provided resistance to H-2Dd-transfected, transporter associated with processing (TAP)-deficient cells from lysis by Ly-49A+ NK cells. Peptide-induced resistance was blocked only by an mAb that binds a conformational determinant on H-2Dd. Moreover, stabilization of "empty" H-2Dd heavy chains by exogenous beta 2-microglobulin did not confer resistance. In contrast to data for MHC class I-restricted T cells that are specific for peptides displayed MHC molecules, these data indicate that NK cells are specific for a peptide-induced conformational determinant, independent of specific peptide. This fundamental distinction between NK cells and T cells further implies that NK cells are sensitive only to global changes in MHC class I conformation or expression, rather than to specific pathogen-encoded peptides. This is consistent with the "missing self" hypothesis, which postulates that NK cells survey tissues for normal expression of MHC class I.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8876216      PMCID: PMC38137          DOI: 10.1073/pnas.93.21.11792

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Analysis of hybrid H-2D and L antigens with reciprocally mismatched aminoterminal domains: functional T cell recognition requires preservation of fine structural determinants.

Authors:  J McCluskey; L Boyd; M Foo; J Forman; D H Margulies; J A Bluestone
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

2.  Molecular basis of the dm1 mutation in the major histocompatibility complex of the mouse: a D/L hybrid gene.

Authors:  Y H Sun; R S Goodenow; L Hood
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

3.  Introduction of soluble protein into the class I pathway of antigen processing and presentation.

Authors:  M W Moore; F R Carbone; M J Bevan
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

4.  YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.

Authors:  G E Piontek; K Taniguchi; H G Ljunggren; A Grönberg; R Kiessling; G Klein; K Kärre
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

5.  Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression. Direct demonstration using beta 2-microglobulin-transfected Daudi cells.

Authors:  A Quillet; F Presse; C Marchiol-Fournigault; A Harel-Bellan; M Benbunan; H Ploegh; D Fradelizi
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

Review 6.  A family of murine NK cell receptors specific for target cell MHC class I molecules.

Authors:  W M Yokoyama; B F Daniels; W E Seaman; R Hunziker; D H Margulies; H R Smith
Journal:  Semin Immunol       Date:  1995-04       Impact factor: 11.130

7.  Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens.

Authors:  G A Evans; D H Margulies; B Shykind; J G Seidman; K Ozato
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

8.  Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

Authors:  K Kärre; H G Ljunggren; G Piontek; R Kiessling
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

9.  H-2Dd exploits a four residue peptide binding motif.

Authors:  M Corr; L F Boyd; E A Padlan; D H Margulies
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  Fine mapping of epitopes by intradomain Kd/Dd recombinants.

Authors:  J P Abastado; C Jaulin; M P Schutze; P Langlade-Demoyen; F Plata; K Ozato; P Kourilsky
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Major histocompatibility complex molecules on parenchymal cells of the target organ protect against autoimmune disease.

Authors:  Hui Shao; Henry J Kaplan; Deming Sun
Journal:  Chem Immunol Allergy       Date:  2007

2.  HLA class I specificity for natural killer cell receptor CD94/NKG2A: two for one in more ways than one.

Authors:  W M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

Review 3.  The mother-child union: the case of missing-self and protection of the fetus.

Authors:  W M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

4.  Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis.

Authors:  F Zappacosta; F Borrego; A G Brooks; K C Parker; J E Coligan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

5.  Self and viral peptides can initiate lysis by autologous natural killer cells.

Authors:  O Mandelboim; S B Wilson; M Valés-Gómez; H T Reyburn; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

6.  Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor.

Authors:  Q R Fan; D C Wiley
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

7.  Efficacy and limitations of natural killer cell depletion in cyclophosphamide-induced tolerance.

Authors:  Ichiro Shimizu; Yukihiro Tomita; Shinji Okano; Toshiro Iwai; Takashi Kajiwara; Tatsushi Onzuka; Ryuji Tominaga
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

8.  The virus-specific and allospecific cytotoxic T-lymphocyte response to lymphocytic choriomeningitis virus is modified in a subpopulation of CD8(+) T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2.

Authors:  C D Peacock; M Y Lin; J R Ortaldo; R M Welsh
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

9.  Recognition of class I MHC by a rat Ly49 NK cell receptor is dependent on the identity of the P2 anchor amino acid of bound peptide.

Authors:  Brian J Ma; Kevin P Kane
Journal:  J Immunol       Date:  2011-08-12       Impact factor: 5.422

10.  Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands.

Authors:  Taewoong Choi; Stephen T Ferris; Naoki Matsumoto; Jennifer Poursine-Laurent; Wayne M Yokoyama
Journal:  J Immunol       Date:  2011-02-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.